Return to List

Study Summary
No. 2009-0040:.......Aids......Damon Vidrine......Behavioral Science
.
Study Summary Title
Study Summary
Number:
2009-0040
Study Title:Decisions to take part in research: Underserved minorities, HIV, and drug use
.
Physician New Patient Referral
Name:Damon VidrinePatients Call:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:Behavioral ScienceReferring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:713-792-8270
Contact us about clinical trials
.
General Information
Disease Group:AidsSupported By:NIH
Phase of Study:N/AReturn
Visit:
N/A
Treatment
Agents:
NoneHome Care:N/A
Treatment Loc:Only outside MDACC at one or more Collaborating Sites or Institutions
Estimated
Length of Stay
in Houston:
N/A
Description/
Intervention:
Unavailable
.
Study Objectives / Outcomes
This study will investigate motivations underlying the decisions of underserved minority individuals to participate in HIV/AIDS clinical research. From an ethical perspective, the study of decisions to take part in research often focuses on participant knowledge and understanding within a philosophy-based framework of informed consent. This study explores the use of a behavioral framework to examine decision making in this vulnerable population. A greater understanding of motivations surrounding decision making is needed because minority populations are disproportionately affected by HIV/AIDS, yet are under-represented in HIV/AIDS clinical research (Gifford et al., 2002; Djomand et al., 2005; Sullivan et al., 2007). This study will build on a previous study of motivations for participating in hypothetical research among underserved African American drug users with or at risk for HIV/AIDS. The specific aims are 1) to elicit and describe perceptions of severity of illness on decisions to participate; 2) to elicit and describe benefits of participating in clinical research as perceived by participants; 3) to elicit and describe burdens (inconveniences, discomfort, risk of harm) of participating in clinical research; 4) to elicit and describe 'cues' or 'triggers' for decisions; and 5) to elicit and describe "self-efficacy" in research decisions—defined in this proposed study as a belief in one's ability to control the research process to one's benefit.
The study design is mixed method, with quantitative and qualitative components. The target population is 250 HIV positive Caucasian, African American and Hispanic participants who receive their healthcare at an urban clinic specializing in HIV/AIDS treatment. The quantitative component will use structured scales and survey questions to measure motivating influences in 200 individuals with HIV. Relationships among variables will be identified in studies representing both high and low risk. The qualitative component will elicit information from 50 participants, using semi-structured, in-depth interviews. Data will be triangulated to produce a complete picture of decisions to participate.
.
Study Status Information
Study Activation / Registration Date:04/10/2009
IRB Review and Approval Date:04/10/2009
Study Type:Behavioral
Recruitment Status:Closed
Projected Accrual:280
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you. Please Contact the Referral Office for more information.

Inclusion Criteria:1) English-speaking

2) Age 21 years or older

Exclusion Criteria:1) Non-English-speaking

2) Age younger than 21 years

.
Links
Registration Number: Not Applicable Clinical Trial

Other Links:
.
Results


Return to Clinical Trials at M.D. Anderson Cancer Center